Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PPM1B | O75688 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13897070 | 0.81 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL28055746 | 0.81 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL22604709 | 0.81 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL15043198 | 0.80 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL1451666 | 0.79 | POLB (0.54) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL7908352 | 0.79 | ALDH1A1 (0.68) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL2137115 | 0.78 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL11515674 | 0.77 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL19615936 | 0.77 | POLB (0.49) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL14789665 | 0.77 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2POLBHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF SE (DE) | 2019-03-26 | — | — | US | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| CN-105358527-A | Oxime ester photoinitiators | BASF SE | 2016-02-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | SULT1E1, COX6B1, SULT1A1 | ALDH1A1 776/4885SMN1; SMN2 2191/4885POLB 156/4885 |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | ALDH1A1 776/4885SMN1; SMN2 2191/4885POLB 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.